2025-12-13 - Analysis Report
Okay, here's a comprehensive analysis of UnitedHealth Group (UNH) based on the provided data.

**0. Report Goal:**  To provide an overview of UNH's current performance and potential investment considerations.

**1. Return Rate Comparison & Alpha/Beta Analysis**

*   **Company Overview:** UnitedHealth Group Inc. is a diversified healthcare company providing health benefits and healthcare services.

*   **Return Rate Comparison:** UNH's cumulative return is -18.17% compared to the S&P 500's (VOO) 102.37%.  This represents a significant divergence of -116.5, placing the relative divergence at 8.5 (near the bottom of its historical divergence range).

*   **Alpha/Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
|------------|---------|-------|---------|-------|--------|
| 2015-2017  | 58.0%  | 66.4% | 30.0%   | 0.1   | 207.9 |
| 2016-2018  | 41.0%  | 70.4% | 26.0%   | 0.1   | 234.9 |
| 2017-2019  | 36.0%  | 73.8% | 14.0%   | 0.2   | 277.2 |
| 2018-2020  | -43.0% | 81.2% | -67.0%  | 0.5   | 330.7 |
| 2019-2021  | 16.0%  | 81.2% | -30.0%  | 1.5   | 473.5 |
| 2020-2022  | -1.0%  | 81.2% | 0.0%    | 1.5   | 500.0 |
| 2021-2023  | 24.0%  | 80.8% | 23.0%   | 0.4   | 496.5 |
| 2022-2024  | -27.0% | 78.8% | -47.0%  | 0.3   | 477.0 |
| 2023-2025  | -61.0% | 79.8% | -128.0% | 1.2   | 309.6 |

*   **Analysis:**
    *   The negative cumulative return significantly lags the S&P 500.
    *   The relative divergence of 8.5 suggests this underperformance is near its worst point historically.
    *   The Alpha/Beta analysis reveals volatile performance.  The alpha values have been strongly negative in recent periods (2018-2025), indicating underperformance relative to the market, after a period of outperformance.  Beta fluctuates, but appears to be increasing recently, reaching high values indicating increasing market correlation.  The CAGR and MDD also illustrate this volatility. The decreasing Cap value could indicate a decrease in the ability to manage funds

**2. Recent Stock Price Fluctuations**

*   **Key Price Points:**
    *   Current Close: 328.37
    *   Last Market Price: 341.84
    *   Previous Close: 336.73
    *   Change: 1.52

*   **Moving Averages:**
    *   5-day SMA: 327.998
    *   20-day SMA: 325.02
    *   60-day SMA: 341.3508

*   **Analysis:** The current price closed below the 60-day SMA but above the 5-day and 20-day SMA, suggesting a possible short-term upward trend, or at least some support near the current price. The last market indicates a increase in price which could signify a sharp rebound

**3. RSI, PPO, Divergence, and Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 64.50 (Approaching overbought territory)
*   **PPO:** 0.37 (Positive, indicating potential upward momentum)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80) Dividend_2.21 (Cash Ratio: 0% on 2025-12-08)
*   **Recent Relative Divergence Change:** 0.8 (+): Short-term increase expected (단기상승)
*   **Expected Return:** -191.2% (Significant expected underperformance vs. S&P 500 over the long term)

*   **Analysis:** The MRI suggests a medium investment recommendation.  The RSI approaching overbought territory could suggest a pullback might be coming. The PPO indicating positive momentum contrasts with the very negative expected return. The "Hybrid Signal" suggests a buy based on a dividend strategy, but with caution given the MRI and potential risks, although it recommends using 90% of available cash. The last market price could be indicative of fluctuation.

**4. Recent News & Significant Events**

*   **Key Themes from News Headlines:**
    *   **Regulatory Scrutiny:** DOJ Amedisys ruling, Optum Lawsuit risks suggest regulatory headwinds
    *   **Potential Upside:** Several articles discuss the potential for UNH to surprise to the upside in 2026.
    *   **Dividend Appeal:** The Motley Fool article highlights the dividend yield as an attractive feature.
    *   **Institutional Holding:** Mairs & Power Balanced Fund continues to hold UNH.
    *   **TradingView Analysis:** "UNH: 50% Inception" (requires further context from the link)
    *   **Daily Updates:** Articles providing daily updates on UNH stock performance.

*   **Analysis:** The news is a mixed bag. The regulatory concerns are definite risks. However, the positive articles suggesting potential upside and the focus on the dividend may offer some support for the stock.

**4-2. Analyst Opinions**

*   **Consensus:**
    *   Key: Buy
    *   Mean: 2.00 (~Buy)
    *   Opinions: 25
    *   Target Price (avg/high/low): 392.24 / 440.00 / 280.00

*   **Analysis:**  Analysts generally have a "Buy" rating on UNH and an average target price of $392.24, suggesting potential upside from the current price. However, there's a wide range in target prices ($280 to $440), indicating some uncertainty in the outlook.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-10-28 | 2.59 | 113.16 B$ |
| 2025-08-11 | 3.76 | 111.62 B$ |
| 2025-05-07 | 6.9  | 109.58 B$ |
| 2024-11-04 | 6.56 | 100.82 B$ |
| 2025-10-28 | 6.56 | 100.82 B$ |

*   **Analysis:** Revenue has been consistently growing, but EPS has been volatile. The most recent EPS is significantly lower than previous quarters, potentially contributing to the recent stock underperformance. The presence of a repeated data row needs to be verified.

**6. Financial Information**

*   **Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $113.16B   | 18.24%        |
| 2025-06-30   | $111.62B   | 17.93%        |
| 2025-03-31   | $109.58B   | 21.70%        |
| 2024-12-31   | $100.81B   | 21.14%        |
| 2024-09-30   | $100.82B   | 22.84%        |

*   **Capital and Profitability:**

| Quarter      | Equity     | ROE   |
|--------------|------------|-------|
| 2025-09-30   | $95.79B   | 2.45% |
| 2025-06-30   | $94.72B   | 3.60% |
| 2025-03-31   | $95.04B   | 6.62% |
| 2024-12-31   | $92.66B   | 5.98% |
| 2024-09-30   | $94.53B   | 6.41% |

*   **Analysis:**  Revenue is growing, but profit margins have decreased recently. Similarly, ROE has decreased, likely driven by the lower recent EPS. This suggests that while the company is increasing its sales, its profitability is being challenged.

**7. Comprehensive Analysis (Summary)**

*   **Bearish Signals:**
    *   Significant underperformance vs. S&P 500.
    *   Very negative expected return.
    *   Decreasing profit margins and ROE.
    *   Recent EPS is lower than prior quarters.
    *   Regulatory risks highlighted in news headlines.

*   **Bullish Signals:**
    *   Analysts generally have a "Buy" rating with upside potential.
    *   Dividend appeal.
    *   Medium investment recommendation from MRI.
    *   Short-term upward trend suggested by moving averages.
    *   Potential upside mentioned in some news articles.

*   **Overall Assessment:**

    UNH presents a mixed picture. While analysts are generally positive and the dividend is attractive, the significant underperformance, declining profitability, and regulatory risks are concerning. The very negative expected return is a major red flag.

*   **Recommendation:**

    Given the significant risks and negative expected return, a **cautious approach is warranted.** Consider the following:

    *   **Due Diligence:** Further research is needed to understand the drivers of the declining profitability and the potential impact of the regulatory headwinds.
    *   **Risk Tolerance:**  Only consider investing if you have a high risk tolerance and a long-term investment horizon.
    *   **Alternative Investments:** Consider alternative investments with more favorable risk-reward profiles.
    *   **Monitor Developments:** Closely monitor news and earnings reports for any changes in the company's outlook.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.